DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Antonia SJ. et al.
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
N Engl J Med 2018;
DOI: 10.1056/NEJMoa1809697.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.